Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment

References

• Surawicz T S, McCarthy B J, Kupelian V, Jukich P J, Bruner J M, Davis F G. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro Oncol 1999; 1: 14–25
   PubMedGoogle Scholar
• Ferreri A J, Abrey L E, Blay J Y, Borisch B, Hochman J, Neuwelt E A, et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 2003; 21: 2407–2414
   PubMed Web of Science ®Google Scholar
• Makino K, Nakamura H, Kino T, Takeshima H, Kuratsu J. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. Surg Neurol 2006; 66: 503–506
   PubMed Web of Science ®Google Scholar
• Haldorsen I, Krossnes B, Aarseth J, Scheie D, Johannesen T, Mella O, Espeland A. Increasing incidence and continued dismal outcome in primary central nervous system lymphoma in Norway 1989–2003, time trends in a 15-year national survey. Cancer 2007; 110: 1803–1814
   PubMed Web of Science ®Google Scholar
• Olson J E, Janney C A, Rao R D, Cerhan J R, Kurtin P J, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002; 95: 1504–1510
   PubMed Web of Science ®Google Scholar
• Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999; 43: 199–201
   PubMed Web of Science ®Google Scholar
• Abrey L, Ferreri A JM. Primary and secondary central nervous system lymphomas in immunocompetent and human immunodeficiency virus–positive patients. Clinical Hematology, 1st edn, N S Young, S L Gerson, K A High, Amsterdam, Netherlands: Elsevier 2006; 564–578
   Google Scholar
• Wolf T, Brodt H R, Fichtlscherer S. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 2005; 46: 207–215
   PubMed Web of Science ®Google Scholar
• Biggar R J, Engels E A, Ly S. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005; 39: 293–299
   PubMed Web of Science ®Google Scholar
• Bashir R, Luka J, Cheloha K, Chamberlain M, Hochberg F. Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 1993; 43: 2358–2362
   PubMed Web of Science ®Google Scholar
• Shen D F, Herbort C P, Tuaillon N, Buggage R R, Egwuagu C E, Chan C C. Detection of toxoplasma gondii DNA in primary intraocular B-cell lymphoma. Mod Pathol 2001; 14: 995–999
   PubMed Web of Science ®Google Scholar
• Chan C C. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 2003; 101: 275–292
   PubMedGoogle Scholar
• Montesinos-Rongen M, Hans V H, Eis-Hübinger A M, Prinz M, Schaller C, Van Roost D, et al. Human herpes virus-8 is not associated with primary central nervous system lymphoma in HIV-negative patients. Acta Neuropathol 2001; 102: 489–495
   PubMed Web of Science ®Google Scholar
• Corboy J R, Garl P J, Kleinschmidt-DeMasters B K. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology 1998; 50: 335–340
   PubMed Web of Science ®Google Scholar
• Martini F, Dolcetti R, Ferreri A J, Ponzoni M, Fumagalli L, Reni M, et al. No association between polyomaviruses and primary central nervous system lymphomas of HIV-seronegative and HIV-positive patients. Cancer Epidemiol Biomarkers Prev 2004; 13: 1819–1820
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Reni M, Pasini F, Calderoni A, Tirelli U, Pivnik A, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology 2002; 58: 1513–1520
   PubMed Web of Science ®Google Scholar
• Bromberg J EC, Siemers M D, Taphoorn M JB. Is a “vanishing tumor” always a lymphoma?. Neurology 2002; 59: 762–764
   PubMed Web of Science ®Google Scholar
• Soo T M, Bernstein M, Provias J, Tasker R, Lozano A, Guha A. Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg 1995; 64: 183–196
   PubMed Web of Science ®Google Scholar
• Miller D C, Hochberg F H, Harris N L, Gruber M L, Louis N L, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958–1989. Cancer 1994; 74: 1383–1397
   PubMed Web of Science ®Google Scholar
• Grimm S A, Pulido J S, Jahnke K, Schiff D, Hall A J, Shenkier T N, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol 2007; 18: 1851–1855
   PubMed Web of Science ®Google Scholar
• Antinori A, De Rossi G, Ammassari A, Cingolani A, Murri R, Di Giuda D, et al. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol 1999; 17: 554–560
   PubMed Web of Science ®Google Scholar
• Abrey L E, Batchelor T T, Ferreri A J, Gospodarowicz M, Pulczynski E J, Zucca E, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005; 23: 5034–5043
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Reni M. Primary central nervous system lymphoma. Crit Rev Oncol Hematol 2007; 63: 257–268
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Blay J Y, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003; 21: 266–272
   PubMed Web of Science ®Google Scholar
• Ferreri A JM, Blay J Y, Reni M, Pasini F, Gubkin A, Tirelli U, et al. Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol 2002; 13: 531–538
   PubMed Web of Science ®Google Scholar
• Chan C C, Buggage R R, Nussenblatt R B. Intraocular lymphoma. Curr Opin Ophthalmol 2002; 13: 411–418
   PubMedGoogle Scholar
• Jahnke K, Schilling A, Heidenreich J, Stein H, Brock M, Thiel E, et al. Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients. Am J Neuroradiol 2005; 26: 2466–2454
   PubMed Web of Science ®Google Scholar
• DeAngelis L M, Ferreri A JM. Central nervous system lymphoma. Lymphoma: Pathology, Diagnosis and Treatment, R Marcus, J W Sweetenham, M E Williams. Cambridge University Press, New York 2007; pp. 200–214
   Google Scholar
• Shenkier T, Blay J-Y, O'Neill B, Poortmans P, Thiel E. Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 2005; 2233–2239
   PubMed Web of Science ®Google Scholar
• Batchelor T, Loeffler J S. Primary CNS lymphoma. J Clin Oncol 2006; 24: 1281–1288
   PubMed Web of Science ®Google Scholar
• Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler O D, Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004; 103: 1869–1875
   PubMed Web of Science ®Google Scholar
• Lin C H, Kuo K T, Chuang S S, Kuo S H, Chang J H, Chang K C, et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphomas of central nervous system origin and peripheral nodal origin. Clin Cancer Res 2006; 12: 1152–1156
   PubMed Web of Science ®Google Scholar
• Camilleri-Broët S, Crinière E, Broët P, Delwail V, Mokhtari K, Moreau A, et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 2006; 107: 190–196
   PubMed Web of Science ®Google Scholar
• Rubenstein J, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, et al. Gene expression and angiotropism in primary CNS lymphoma. Blood 2006; 107: 3716–3723
   PubMed Web of Science ®Google Scholar
• Kadoch C, Treseler P, Rubenstein J. Molecular pathogenesis of primary CNS lymphoma. Neurosurg Focus 2006; 21: E1
   PubMedGoogle Scholar
• Tu P H, Giannini C, Judkins A R, Schwalb J M, Burack R, O'Neill B P, et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol 2005; 23: 5718–5727
   PubMed Web of Science ®Google Scholar
• Cheuk W, Walford N, Lou J, Lee A K, Fung C F, Au K H, et al. Primary histiocytic lymphoma of the central nervous system: a neoplasm frequently overshadowed by a prominent inflammatory component. Am J Surg Pathol 2001; 25: 1372–1379
   PubMed Web of Science ®Google Scholar
• Sun W, Nordberg M L, Fowler M R. Histiocytic sarcoma involving the central nervous system: clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol 2003; 27: 258–265
   PubMed Web of Science ®Google Scholar
• Abrey L, Yahalom J, De Angelis L. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144–3150
   PubMed Web of Science ®Google Scholar
• Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001; 19: 742–749
   PubMed Web of Science ®Google Scholar
• DeAngelis L M, Seiferheld W, Schold S C, Fisher B, Schultz C J. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002; 20: 4643–4648
   PubMed Web of Science ®Google Scholar
• Shah G D, Yahalom J, Correa D D, Lai R K, Raizer J J, Schiff D, et al. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 2007; 25: 4730–4735
   PubMed Web of Science ®Google Scholar
• Ferreri A J, Dell'Oro S, Foppoli M, Bernardi M, Brandes A A, Tosoni A, et al. MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphoma. Neurology 2006; 66: 1435–1438
   PubMed Web of Science ®Google Scholar
• Issa M, Hwang J, Karch K, Fridlyand M, Prados T, Batchelor K, et al. Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: a pilot study with biomarker analysis. J Clin Oncol 2006; 24, Abstract 7595
   Web of Science ®Google Scholar
• Rubenstein J L, Combs J, Rosenberg Levy A, McDermott M, Damon L, Ignoffo R, et al. Rituximab in CNS lymphoma: targeting the leptomeningeal compartment. Blood 2003; 101: 466–468
   PubMed Web of Science ®Google Scholar
• Rubenstein J L, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, et al. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 2007; 25: 1350–1356
   PubMed Web of Science ®Google Scholar
• Barrans S L, Fenton J A, Banham A, Owen R G, Jack A S. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004; 104: 2933–2935
   PubMed Web of Science ®Google Scholar
• Banham A H, Connors J M, Brown P J, Cordell J L, Ott G, Sreenivasan G, et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res 2005; 11: 1065–1072
   PubMed Web of Science ®Google Scholar
• Roy S, Josephson S A, Fridlyand J, Karch J, Kadoch C, Karrim J, et al. Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol 2008; 26: 96–105
   PubMed Web of Science ®Google Scholar
• Kadoch C, Shuman M, Rubenstein J L. Complement activation and resistance within the cerebrospinal fluid following intraventricular administration of anti-CD20 in the treatment of central nervous system lymphoma. Blood 2007; 110, Abstract 3418
   Web of Science ®Google Scholar
• Tun H W, Personett D, Baskerville K A, Menke D M, Jaeckle K A, Kreinest P, et al. Pathway analysis of primary central nervous system lymphoma. Blood 2008; 111: 3200–3210
   PubMed Web of Science ®Google Scholar